Given the availability of these agents for treating obesity and type 2 diabetes, along with the several agents in development, and current demand, trends in clinical practice have shifted towards personalized and tailored use of these agent for individual patient needs.6 GLP-1 and GIP agonist offer various benefits in managing obesity and type 2 diabetes
Before & After Real patients
Ultherapy Prime allowed the doctor to seamlessly transition between shallow, medium, and deep tissue targets, customizing the energy delivery to her unique facial anatomy without overlapping unnecessary heat
Glue-Free Innovation for Faster, Cleaner Treatments Noemi Free Lift is the worlds first glue-free lifting system
For research purposes where compound integrity matters, verifiable Janoshik testing is the more important factor than the lowest price
By incorporating GLP-1 medications after VSG, patients can potentially avoid the need for additional surgeries and still achieve significant weight loss